Tokyo, Aug. 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058914) titled 'A retrospective study evaluating the effectiveness of therapeutic guidance for lifestyle-related diseases' on Aug. 28.
Study Type:
Observational
Primary Sponsor:
Institute - Kimura Naika Clinic
Condition:
Condition - Any of the following: diabetes, hypertension, or dyslipidemia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To retrospectively evaluate changes in lifestyle survey responses and clinical parameters at each of the first to third sessions of therapeutic guidance provided to patients with lifestyle-related diseases (diabetes, hypertension, or dyslipidemia), and to clarify how such guidance influences patients' lifestyle habits and health status.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - All data collected at our institution between June 1, 2024, and May 31, 2025.
Key exclusion criteria - Individuals who requested to be excluded from the study through the opt-out process regarding the study's s purpose and content
Target Size - 87
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 08 Month 12 Day
Date of IRB - 2025 Year 08 Month 26 Day
Anticipated trial start date - 2025 Year 11 Month 01 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067373
Disclaimer: Curated by HT Syndication.
